Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanuel S Antonarakis

Showing results (1-10 of 477) with videos related to

Pageof 48
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 23, 2017
Circulating Tumor Cell Eradication as an Intermediate Efficacy End Point for Metastatic Castration-Resistant Prostate Cancer: Is There Enough Evidence?Emmanuel S Antonarakis
The Journal of Urology|October 9, 2016
Editorial CommentEmmanuel S Antonarakis
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 13, 2018
Reply to C. Ren et alEmmanuel S Antonarakis
The Lancet. Oncology|August 31, 2016
Inherited HSD3B1 polymorphisms and hormonal therapy resistanceEmmanuel S Antonarakis
Asian Journal of Andrology|July 12, 2011
Abiraterone acetate for prostate cancer: a new era of hormonal therapiesEmmanuel S Antonarakis
The Lancet. Oncology|June 9, 2018
Abiraterone plus olaparib in prostate cancer: a new form of synthetic lethality?Emmanuel S Antonarakis
The Lancet. Oncology|September 14, 2019
Targeting lineage plasticity in prostate cancerEmmanuel S Antonarakis
Cancers|January 19, 2018
AR Signaling in Human Malignancies: Prostate Cancer and BeyondEmmanuel S Antonarakis
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|June 30, 2007
Visual vignette. Necrobiosis lipoidicaEmmanuel S Antonarakis
European Urological Review|June 22, 2013
Management of metastatic castration-resistant prostate cancerEmmanuel S Antonarakis
Pageof 48

Showing results (1-10 of 477) with videos related to

Sort By:
Pageof 48
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 23, 2017
Circulating Tumor Cell Eradication as an Intermediate Efficacy End Point for Metastatic Castration-Resistant Prostate Cancer: Is There Enough Evidence?Emmanuel S Antonarakis
The Journal of Urology|October 9, 2016
Editorial CommentEmmanuel S Antonarakis
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 13, 2018
Reply to C. Ren et alEmmanuel S Antonarakis
The Lancet. Oncology|August 31, 2016
Inherited HSD3B1 polymorphisms and hormonal therapy resistanceEmmanuel S Antonarakis
Asian Journal of Andrology|July 12, 2011
Abiraterone acetate for prostate cancer: a new era of hormonal therapiesEmmanuel S Antonarakis
The Lancet. Oncology|June 9, 2018
Abiraterone plus olaparib in prostate cancer: a new form of synthetic lethality?Emmanuel S Antonarakis
The Lancet. Oncology|September 14, 2019
Targeting lineage plasticity in prostate cancerEmmanuel S Antonarakis
Cancers|January 19, 2018
AR Signaling in Human Malignancies: Prostate Cancer and BeyondEmmanuel S Antonarakis
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|June 30, 2007
Visual vignette. Necrobiosis lipoidicaEmmanuel S Antonarakis
European Urological Review|June 22, 2013
Management of metastatic castration-resistant prostate cancerEmmanuel S Antonarakis
Pageof 48